Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Ulm

Showing results (121-130 of 125) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 125 results.
Circulation|July 15, 1997
Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) TrialA Kastrati, H Schühlen, J Hausleiter, et al.
International Journal of Oncology|June 19, 1998
Disease-adapted relapse therapy for ovarian cancer: results of a prospective studyW Kuhn, B Schmalfeldt, L Pache, et al.
British Journal of Cancer|April 17, 1999
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIcW Kuhn, B Schmalfeldt, U Reuning, et al.
Circulation|April 26, 2000
Endovascular irradiation from beta-particle-emitting gold stents results in increased neointima formation in a porcine restenosis modelC Schulz, C Niederer, C Andres, et al.
The New England Journal of Medicine|April 25, 1996
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stentsA Schömig, F J Neumann, A Kastrati, et al.
Pageof 13

Showing results (121-130 of 125) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 125 results.
Circulation|July 15, 1997
Restenosis after coronary stent placement and randomization to a 4-week combined antiplatelet or anticoagulant therapy: six-month angiographic follow-up of the Intracoronary Stenting and Antithrombotic Regimen (ISAR) TrialA Kastrati, H Schühlen, J Hausleiter, et al.
International Journal of Oncology|June 19, 1998
Disease-adapted relapse therapy for ovarian cancer: results of a prospective studyW Kuhn, B Schmalfeldt, L Pache, et al.
British Journal of Cancer|April 17, 1999
Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIcW Kuhn, B Schmalfeldt, U Reuning, et al.
Circulation|April 26, 2000
Endovascular irradiation from beta-particle-emitting gold stents results in increased neointima formation in a porcine restenosis modelC Schulz, C Niederer, C Andres, et al.
The New England Journal of Medicine|April 25, 1996
A randomized comparison of antiplatelet and anticoagulant therapy after the placement of coronary-artery stentsA Schömig, F J Neumann, A Kastrati, et al.
Pageof 13